Accuray (ARAY) is Initiated by RBC Capital Mkts to Sector Perform according to the research report released to the investors. The brokerage firm has set the Price Target of the shares at $8. The shares recommendation by the Brokerage Firm was released on Dec-22-2015.
Accuray Incorporated (NASDAQ:ARAY) : On Thursday heightened volatility was witnessed in Accuray Incorporated (NASDAQ:ARAY) which led to swings in the share price. The shares opened for trading at $6.89 and hit $7.18 on the upside , eventually ending the session at $7.09, with a gain of 2.9% or 0.2 points. The heightened volatility saw the trading volume jump to 858,766 shares. The 52-week high of the share price is $10.01 and the company has a market cap of $566 million. The 52-week low of the share price is at $4.8 .
During the last several months other analysts have commented on the company rating. Citigroup initiates coverage on Accuray Incorporated (NASDAQ:ARAY) In a research note issued to the investors, the brokerage major announces a price-target of $6 per share.The shares have been rated Sell. The rating by the firm was issued on November 12, 2015.
Accuray Incorporated (NASDAQ:ARAY) has received a hold rating for the short term, according to the latest rank of 3 from research firm, Zacks. The company received an average rating of 1.5 from 6 analysts. 4 have rated it as a strong buy. 1 analysts recommended buying the shares. 1 analysts have rated the company at hold.
Accuray Incorporated (NASDAQ:ARAY): 6 Analyst have given the stock of Accuray Incorporated (NASDAQ:ARAY) a near short term price target of $10.5. The standard deviation reading, which is a measure by which the stock price is expected to swing away from the mean estimate, is at $1.05. The higher price target estimate is at $12 while the lower price estimates are fixed at $9.
Shares of Accuray Incorporated rose by 6.3% in the last five trading days and 3.81% for the last 4 weeks. Accuray Incorporated is up 12.9% in the last 3-month period. Year-to-Date the stock performance stands at -6.09%.”
Accuray, Inc. manufactures image-guided radiosurgery devices. The Company is based in the United States and its core product, the CyberKnife Stereotactic Radiosurgery System, combines image-guidance with robotics to offer unparalleled flexibility and accuracy. Accuray’s focus is to revolutionize the treatment of solid cancers throughout the body by the precise delivery of high doses of radiation using the CyberKnife Stereotactic Radiosurgery System.